Login / Signup

Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate.

Judy van StralenGurdeep ParharAnita ParharValérie TourjmanSohail KhattakTahira AhmedGraeme A E DonnellyJodan Ratz
Published in: Journal of attention disorders (2023)
PRC-063 and LDX significantly improved ADHD symptomatology and functioning and were well-tolerated.
Keyphrases
  • attention deficit hyperactivity disorder
  • autism spectrum disorder
  • working memory
  • cross sectional
  • childhood cancer
  • young adults
  • smoking cessation